Meyahealth
HomeGeneticsConditionDystonia 16
Back to Condition
Dystonia 16
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Dystonia 16

Dystonia 16 is a rare, genetically inherited movement disorder caused by mutations in the PRKRA gene, leading to progressive muscle contractions and, in some cases, mild parkinsonism.

Overview

Dystonia 16 belongs to a group of conditions characterized by involuntary movements, twisting (torsion) and tensing of various muscles, and unusual positioning of affected body parts. The disorder can appear at any age, but most often begins in childhood.

Symptoms

The signs and symptoms vary among individuals. Common patterns include:

  • Initial involvement of muscles in one or both arms or legs, causing abnormal limb positions that may be painful and impair walking.
  • Neck muscle involvement leading to retrocollis (head pulled backward with chin elevated).
  • Oral‑facial involvement (oromandibular dystonia) affecting jaw, lips, and tongue, resulting in difficulty opening/closing the mouth, swallowing, and speech.
  • Laryngeal dystonia causing a quiet, breathy voice or unclear speech.
  • Gradual spread to most body muscles over time.
  • In some individuals, a pattern of parkinsonism may develop, including bradykinesia, muscle rigidity, tremor, and postural instability; this is usually mild.

Typical pharmacologic treatments for movement disorders generally do not improve the signs and symptoms of Dystonia 16.

Frequency

Dystonias are estimated to affect 250,000 people in the United States. Dystonia 16 is a rare form; its exact prevalence is unknown.

Causes & Risk Factors

Dystonia 16 is caused by mutations in the PRKRA gene, which encodes the protein PACT. PACT regulates cellular stress responses by turning on signals that reduce protein production, protecting cells from damage. Under prolonged stress, these signals can trigger apoptosis.

Mutated PRKRA produces abnormal PACT proteins that alter stress‑response signaling, increasing cell death rates. Excessive loss of neurons in specific brain regions is thought to impair motor control, producing the clinical features of Dystonia 16. The reason why brain cells are preferentially affected remains unclear.

Gene Information

  • PRKRA

Inheritance

Dystonia 16 is usually inherited in an autosomal recessive pattern, meaning both copies of the PRKRA gene carry mutations. Typically, each parent is a carrier without symptoms. In some cases, one mutated allele is inherited from an unaffected parent and the second allele arises de novo during gametogenesis or early embryonic development.

Some studies suggest possible autosomal dominant inheritance, where a single altered gene copy may be sufficient to cause disease.

Other Names

  • DYT‑PRKRA
  • DYT16
  • Young‑onset dystonia‑parkinsonism

Additional Information & Resources

Genetic Testing Information

  • Genetic Testing Registry: Dystonia 16

Genetic and Rare Diseases Information Center

  • Dystonia 16

Patient Support and Advocacy Resources

  • National Organization for Rare Disorders (NORD)

Catalog of Genes and Diseases from OMIM

  • DYSTONIA 16; DYT16

Scientific Articles on PubMed

  • PubMed

References

  • Camargos S, Scholz S, Simon‑Sanchez J, et al. DYT16, a novel young‑onset dystonia‑parkinsonism disorder: identification of a segregating mutation in the stress‑response protein PRKRA. Lancet Neurol. 2008 Mar;7(3):207‑15. doi:10.1016/S1474-4422(08)70022‑X.
  • Dos Santos CO, da Silva‑Junior FP, Puga RD, et al. The prevalence of PRKRA mutations in idiopathic dystonia. Parkinsonism Relat Disord. 2018 Mar;48:93‑96. doi:10.1016/j.parkreldis.2017.12.015.
  • Seibler P, Djarmati A, Langpap B, et al. A heterozygous frameshift mutation in PRKRA (DYT16) associated with generalised dystonia in a German patient. Lancet Neurol. 2008 May;7(5):380‑1. doi:10.1016/S1474-4422(08)70075‑9.
  • Vaughn LS, Bragg DC, Sharma N, et al. Altered activation of protein kinase PKR and enhanced apoptosis in dystonia cells carrying a mutation in PKR activator protein PACT. J Biol Chem. 2015 Sep 11;290(37):22543‑57. doi:10.1074/jbc.M115.669408.
  • Yong Y, Luo J, Ke ZJ. dsRNA binding protein PACT/RAX in gene silencing, development and diseases. Front Biol (Beijing). 2014 Oct;9(5):382‑388. doi:10.1007/s11515‑014‑1325‑z.
  • Zech M, Castrop F, Schormair B, et al. DYT16 revisited: exome sequencing identifies PRKRA mutations in a European dystonia family. Mov Disord. 2014 Oct;29(12):1504‑10. doi:10.1002/mds.25981.

Frequently Asked Questions

The earliest signs of Dystonia 16 often appear in childhood, commonly starting with involuntary muscle contractions in one or both arms or legs. This can lead to abnormal limb positions, pain, and difficulty walking. Over time, the dystonia may spread to other body parts, affecting the neck (causing the head to pull backward), jaw, lips, and tongue (leading to problems with speech, swallowing, and mouth control). In some individuals, mild parkinsonism, characterized by slow movement, rigidity, or tremor, may also develop.
Given that standard pharmacologic treatments for movement disorders generally do not improve Dystonia 16 symptoms, management focuses on supportive and symptomatic therapies. These may include physical therapy, occupational therapy, and speech therapy to help maintain mobility, improve function, and manage difficulties with swallowing or speaking. Botulinum toxin injections can sometimes be used to relax specific muscles affected by severe dystonia, and deep brain stimulation (DBS) may be considered in some cases, although its effectiveness for Dystonia 16 is still being evaluated.
Dystonia 16 is a genetically inherited disorder caused by mutations in the PRKRA gene. It is typically inherited in an autosomal recessive pattern, meaning a child must inherit two copies of the mutated gene (one from each parent) to develop the condition. If both parents are carriers, there is a 25% chance with each pregnancy that their child will be affected. Genetic counseling is important for affected individuals and their families to understand the inheritance pattern, assess recurrence risks, and discuss options for genetic testing for family members or future pregnancies.
Individuals with Dystonia 16 can face significant challenges with daily activities due to muscle contractions affecting various body parts. Oral-facial dystonia can make eating and speaking difficult, requiring speech therapy and dietary modifications. Limb involvement can impair walking and fine motor skills, necessitating physical and occupational therapy, assistive devices, and home modifications. Support groups and specialized care teams can help individuals and families navigate these challenges and access appropriate resources.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA

About UsTerms & PolicyFAQ